Loading...
ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK‐AKT Signaling
BACKGROUND: Cardiac hypertrophy has been recognized as an important independent risk factor for the development of heart failure and increases the risk of cardiac morbidity and mortality. A disintegrin and metalloprotease 23 (ADAM23), a member of ADAM family, is involved in cancer and neuronal diffe...
Na minha lista:
| Udgivet i: | J Am Heart Assoc |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6222933/ https://ncbi.nlm.nih.gov/pubmed/30371220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.008604 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|